share_log

Clearmind Medicine | EFFECT: Others

SEC announcement ·  Mar 25 06:03
Summary by Moomoo AI
Clearmind Medicine Inc., a company listed in the United States, has received a Notice of Effectiveness from the Securities and Exchange Commission (SEC) on March 22, 2024. The notice, identified by Accession Number 0001213900-24-024410 and Submission Type POS AM, signifies that the company's filing has been formally accepted by the SEC. The effectiveness of the filing, associated with File Number 333-276913, is a critical step in the regulatory process for Clearmind Medicine Inc.
Clearmind Medicine Inc., a company listed in the United States, has received a Notice of Effectiveness from the Securities and Exchange Commission (SEC) on March 22, 2024. The notice, identified by Accession Number 0001213900-24-024410 and Submission Type POS AM, signifies that the company's filing has been formally accepted by the SEC. The effectiveness of the filing, associated with File Number 333-276913, is a critical step in the regulatory process for Clearmind Medicine Inc.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more